Literature DB >> 1405477

Prenatal diagnosis of Canavan disease.

R Matalon1, K Michals, P Gashkoff, R Kaul.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1405477     DOI: 10.1007/bf02435985

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  5 in total

1.  Diagnosis of organic acidemias by gas chromatography--mass spectrometry.

Authors:  S I Goodman; S P Markey
Journal:  Lab Res Methods Biol Med       Date:  1981

2.  N-acetylaspartic aciduria due to aspartoacylase deficiency--a new aetiology of childhood leukodystrophy.

Authors:  L Hagenfeldt; I Bollgren; N Venizelos
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

3.  Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease.

Authors:  R Matalon; K Michals; D Sebesta; M Deanching; P Gashkoff; J Casanova
Journal:  Am J Med Genet       Date:  1988-02

4.  SSIEM Award. Aspartoacylase deficiency: the enzyme defect in Canavan disease.

Authors:  R Matalon; R Kaul; J Casanova; K Michals; A Johnson; I Rapin; P Gashkoff; M Deanching
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

5.  Purification, characterization, and localization of aspartoacylase from bovine brain.

Authors:  R Kaul; J Casanova; A B Johnson; P Tang; R Matalon
Journal:  J Neurochem       Date:  1991-01       Impact factor: 5.372

  5 in total
  11 in total

1.  First-trimester prenatal diagnosis of Canavan disease.

Authors:  M O Rolland; P Divry; G Mandon; J M Thoulon; A Fiumara; M Mathieu
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

2.  Prenatal diagnosis for Canavan disease: the use of DNA markers.

Authors:  R Matalon; R Kaul; G P Gao; K Michals; R G Gray; S Bennett-Briton; A Norman; M Smith; C Jakobs
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  Prenatal detection of Canavan disease by measurement of N-acetyl-L-aspartate in amniotic fluid.

Authors:  R I Kelley
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

4.  The single cell as a tool for genetic testing: credibility, precision, implication.

Authors:  Keren Dotan; Baruch Feldman; Boleslaw Goldman; Yehuda Peri; Leah Peleg
Journal:  J Assist Reprod Genet       Date:  2010-03-03       Impact factor: 3.412

5.  Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease.

Authors:  Alessandra Colaianni; Subhashini Chandrasekharan; Robert Cook-Deegan
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

6.  Reliable prenatal diagnosis of Canavan disease (aspartoacylase deficiency): comparison of enzymatic and metabolite analysis.

Authors:  M J Bennett; K M Gibson; W G Sherwood; P Divry; M O Rolland; O N Elpeleg; P Rinaldo; C Jakobs
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

7.  Canavan disease: mutations among Jewish and non-Jewish patients.

Authors:  R Kaul; G P Gao; M Aloya; K Balamurugan; A Petrosky; K Michals; R Matalon
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

Review 8.  Canavan disease: biochemical and molecular studies.

Authors:  R Matalon; R Kaul; K Michals
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

9.  Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease.

Authors:  B J Zeng; Z H Wang; L A Ribeiro; P Leone; R De Gasperi; S J Kim; S Raghavan; E Ong; G M Pastores; E H Kolodny
Journal:  J Inherit Metab Dis       Date:  2002-11       Impact factor: 4.982

10.  Canavan disease: molecular basis of aspartoacylase deficiency.

Authors:  R Kaul; G P Gao; K Balamurugan; R Matalon
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.